1235 related articles for article (PubMed ID: 33191068)
1. Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.
Ye M; Luo G; Ye D; She M; Sun N; Lu YJ; Zheng J
Phytomedicine; 2021 May; 85():153401. PubMed ID: 33191068
[TBL] [Abstract][Full Text] [Related]
2. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
[TBL] [Abstract][Full Text] [Related]
3. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
Gao LQ; Xu J; Chen SD
Chin J Integr Med; 2020 Jul; 26(7):527-532. PubMed ID: 32632717
[TBL] [Abstract][Full Text] [Related]
4. Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019.
Xing Y; Hua YR; Shang J; Ge WH; Liao J
Chin J Nat Med; 2020 Dec; 18(12):941-951. PubMed ID: 33357725
[TBL] [Abstract][Full Text] [Related]
5. In silico analysis of the potential mechanism of a preventive Chinese medicine formula on coronavirus disease 2019.
Wu H; Gong K; Qin Y; Yuan Z; Xia S; Zhang S; Yang J; Yang P; Li L; Xie M
J Ethnopharmacol; 2021 Jul; 275():114098. PubMed ID: 33831468
[TBL] [Abstract][Full Text] [Related]
6. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
7. Study on the mechanism of treating COVID-19 with Shenqi Wan based on network pharmacology.
Ye XW; Deng YL; Zhang X; Liu MM; Liu Y; Xie YT; Wan Q; Huang M; Zhang T; Xi JH; Zhang JL
Drug Dev Ind Pharm; 2021 Aug; 47(8):1279-1289. PubMed ID: 34605344
[TBL] [Abstract][Full Text] [Related]
8. Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus
Li X; Lin H; Wang Q; Cui L; Luo H; Luo L
Drug Dev Ind Pharm; 2020 Dec; 46(12):1947-1959. PubMed ID: 33054436
[TBL] [Abstract][Full Text] [Related]
9. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.
Wang J; Ge W; Peng X; Yuan L; He S; Fu X
Mol Divers; 2022 Apr; 26(2):1175-1190. PubMed ID: 34105049
[TBL] [Abstract][Full Text] [Related]
10. Bioactive Components of
Yuan H; Liu L; Zhou J; Zhang T; Daily JW; Park S
J Med Food; 2022 Apr; 25(4):355-366. PubMed ID: 35438554
[TBL] [Abstract][Full Text] [Related]
11. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
[TBL] [Abstract][Full Text] [Related]
12. Exploration of molecular targets and mechanisms of Chinese medicinal formula Acacia Catechu -Scutellariae Radix in the treatment of COVID-19 by a systems pharmacology strategy.
Feng T; Zhang M; Xu Q; Song F; Wang L; Gai S; Tang H; Wang S; Zhou L; Li H
Phytother Res; 2022 Nov; 36(11):4210-4229. PubMed ID: 35859316
[TBL] [Abstract][Full Text] [Related]
13. The pharmacological mechanism of Huashi Baidu Formula for the treatment of COVID-19 by combined network pharmacology and molecular docking.
Cai Y; Zeng M; Chen YZ
Ann Palliat Med; 2021 Apr; 10(4):3864-3895. PubMed ID: 33691446
[TBL] [Abstract][Full Text] [Related]
14. [Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP].
Ma J; Huo XQ; Chen X; Zhu WX; Yao MC; Qiao YJ; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1219-1224. PubMed ID: 32281328
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (
Wang L; Wang Y; Yang W; He X; Xu S; Liu X; He Y; Hu Q; Yuan D; Jin T
J Med Microbiol; 2021 Jul; 70(7):. PubMed ID: 34313585
[No Abstract] [Full Text] [Related]
16. Exploring the mechanism of Corbrin capsules in the intervention of AKI-COVID-19 based on network pharmacology combined with GEO dataset.
Qin XJ; Hu WJ; Xu XJ
Gene; 2024 Jul; 916():148438. PubMed ID: 38579905
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking.
Simayi J; Nuermaimaiti M; Wumaier A; Khan N; Yusufu M; Nuer M; Maihemuti N; Bayinsang ; Adurusul K; Zhou W
Medicine (Baltimore); 2022 Jan; 101(1):e28286. PubMed ID: 35029877
[TBL] [Abstract][Full Text] [Related]
18. [A systematic pharmacological investigation of pharmacologically active ingredients in Toujie Quwen granules for treatment of COVID-19].
Ma S; Zhang X; Cen J; Hong G; Hong S; Ju W
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1072-1080. PubMed ID: 32895172
[TBL] [Abstract][Full Text] [Related]
19. Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19.
Xia QD; Xun Y; Lu JL; Lu YC; Yang YY; Zhou P; Hu J; Li C; Wang SG
Cell Prolif; 2020 Dec; 53(12):e12949. PubMed ID: 33140889
[TBL] [Abstract][Full Text] [Related]
20. Identification of bioactive compounds and potential mechanisms of scutellariae radix-coptidis rhizoma in the treatment of atherosclerosis by integrating network pharmacology and experimental validation.
Ji L; Song T; Ge C; Wu Q; Ma L; Chen X; Chen T; Chen Q; Chen Z; Chen W
Biomed Pharmacother; 2023 Sep; 165():115210. PubMed ID: 37499457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
